Kobayashi Pharmaceutical Co., Ltd. Stock

Equities

4967

JP3301100008

Personal Products

Delayed Japan Exchange 08:25:09 2024-07-18 pm EDT 5-day change 1st Jan Change
5,615 JPY -0.07% Intraday chart for Kobayashi Pharmaceutical Co., Ltd. -0.23% -17.33%
Sales 2024 * 174B 1.11B Sales 2025 * 185B 1.17B Capitalization 418B 2.65B
Net income 2024 * 15.68B 99.69M Net income 2025 * 19.62B 125M EV / Sales 2024 * 1.98 x
Net cash position 2024 * 72.68B 462M Net cash position 2025 * 79.1B 503M EV / Sales 2025 * 1.84 x
P/E ratio 2024 *
26.8 x
P/E ratio 2025 *
21.4 x
Employees 3,534
Yield 2024 *
1.83%
Yield 2025 *
1.87%
Free-Float 59.84%
More Fundamentals * Estimated data
Dynamic Chart
Kobayashi Pharmaceutical Co., Ltd.(TSE:4967) dropped from S&P Japan Mid Cap 100 CI
Japan companies hog the spotlight as hedge funds tout their top Asia picks RE
A second Kobayashi Pharma Japan factory inspected over deaths RE
Kobayashi factory searched over deaths possibly linked to supplements RE
Kobayashi Pharmaceutical Recalls 'Beni-Koji' Supplement Following Report of Death, Kidney Damage MT
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023. CI
Kobayashi Pharmaceutical Co., Ltd's Equity Buyback announced on November 7, 2023, has closed with 1,924,600 shares, for ¥11,999.88 million. CI
Kobayashi Pharmaceutical Co., Ltd. acquired Focus Consumer Healthcare, LLC. CI
Kobayashi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Organ Technologies Inc announced that it has received funding from Kobayashi Pharmaceutical Co., Ltd. CI
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022. CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 1, 2022, has closed with 1,150,602 shares, representing 1.49% for ¥9,991.92 million. CI
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,265,800 shares, representing 1.64% for ¥9,999.82 million. CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan. CI
Kobayashi Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Full Year 2022 CI
More news
1 day-0.11%
1 week-0.23%
Current month+7.47%
1 month+1.17%
3 months+1.98%
6 months-15.12%
Current year-17.33%
More quotes
1 week
5 549.00
Extreme 5549
5 656.00
1 month
5 016.00
Extreme 5016
5 681.00
Current year
4 700.00
Extreme 4700
6 866.00
1 year
4 700.00
Extreme 4700
7 933.00
3 years
4 700.00
Extreme 4700
10 470.00
5 years
4 700.00
Extreme 4700
13 120.00
10 years
3 045.00
Extreme 3045
13 120.00
More quotes
Managers TitleAgeSince
Chairman 84 62-02-28
Director of Finance/CFO - -
President 53 98-02-28
Members of the board TitleAgeSince
Director/Board Member 91 08-05-31
President 53 98-02-28
Chairman 84 62-02-28
More insiders
Date Price Change Volume
24-07-18 5,615 -0.07% 29 700
24-07-18 5,619 +0.12% 398,300
24-07-17 5,612 +0.61% 295,900
24-07-16 5,578 -0.85% 405,200
24-07-12 5,626 -0.07% 535,300

Delayed Quote Japan Exchange, July 18, 2024 at 08:25 pm EDT

More quotes
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
5,619 JPY
Average target price
5,941 JPY
Spread / Average Target
+5.74%
Consensus